CIK 0001297184 · Large accelerated filer
Amphastar Pharmaceuticals, Inc.
Sign in to watch- Ticker
- AMPH
- Exchange
- Nasdaq
- Industry
- Pharmaceutical Preparations
- FY end
- Dec 31
- Entity type
- operating
- EIN
- 330702205
- Phone
- 909-980-9484
- Business address
- 11570 SIXTH STREET, RANCHO CUCAMONGA, CA, 91730
- 4 Open-market sale President and General Counsel sold 20,000 shares at an average $19.43 ($388,638)
- 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 67,207 shares (to pay taxes)
- 4 Open-market sale Director sold 16,598 shares at $19.90 ($330,318)
- 4 Grant or award EVP, Production Center acquired 8,969 shares (grant or award)
- 4 Grant or award CFO, SVP & Treasurer acquired 22,359 shares (grant or award)
- 4 Grant or award President and General Counsel acquired 39,919 shares (grant or award)
- 4 Grant or award CEO & Chief Scientific Officer acquired 139,716 shares (grant or award)
- 4 Open-market sale CFO, SVP & Treasurer sold 19,801 shares at $20.10 ($398,004)
- 4 Open-market sale President and General Counsel sold 700 shares at $20.45 ($14,315)
- 4 Open-market sale President and General Counsel sold 18,627 shares at an average $19.42 ($361,747)
- 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $19.48 ($10,186)
- 4 Shares withheld for taxes CEO & Chief Scientific Officer gave up 830,089 shares (to pay taxes)
- 4 Open-market sale Director sold 7,866 shares at $18.87 ($148,430)
- 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $18.96 ($9,917)
- 4 Open-market sale Director sold 7,862 shares at $18.34 ($144,210)
- 4 Open-market sale CFO, SVP & Treasurer sold 6,226 shares at $19.67 ($122,465)
- 4 Open-market sale Director sold 7,862 shares at $19.25 ($151,344)
- 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $18.15 ($9,493)
- 4 Open-market sale Director sold 7,862 shares at $18.94 ($148,895)
- 4 Open-market sale EVP, QA & Regulatory Affairs sold 523 shares at $18.81 ($9,839)
Page 22 of 31 · 601 filings